Research Article
Cardiorenal Syndrome Type 5: In Vitro Cytotoxicity Effects on Renal Tubular Cells and Inflammatory Profile
Table 1
Clinical and biochemistry parameter about CRS Type 5 patients enrolled.
| | 
 |  |  | CRS Type 5 patients |  | 
 |  | Female () | 3/11 |  | Age (years) |  |  | Creatinine baseline (mg/dL) | 1.06 (0.95–1.41) |  | eGFR baseline (mL/min/1.73 m2) | 62 (50–75) |  | Creatinine admission (mg/dL) | 1.85 (0.77–3.64) |  | eGFR admission (mL/min/1.73 m2) | 36 (17.5–86) |  | Temperature (°C) | 38.3 (36.1–38.9) |  | Urine output (mL/day) | 3040 (1542–3225) |  | Urea (mg/dl) | 91 (59–192) |  | Na (mEq/L) | 138 (135–144) |  | K (mEq/L) | 3.9 (3.67–4.1) |  | White blood cells (/mm3) | 10.8 (7.25–14.2) |  | Platelets (/mm3) | 133 (109–149) |  | PaO2/FiO2 | 241.5 (194.5–273.5) |  | Nonsurvivors () | 3/11 |  | CRRT () | 4/11 |  | 
 | 
 |